The Effect of GB1 on DSS-Induced Colitis in WT and Nlrp3-/- Mice
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26094016 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ziyi Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Biflavonoids, Colitis, Colitis, Ulcerative. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangzhou Science and Technology Plan Project, National Major Scientific and Technological Special Project for "Significant New Drugs De-velopment", Key project at central·government level: The ability establishment of sustainable use for valuable Chinese medicine resources.
Abstract (Originalsprache)
This study investigated the protective effects of Garcinia biflavonoid 1 (GB1) against dextran sulfate sodium (DSS)-induced ulcerative colitis and its underlying mechanisms. Using wild-type (WT) and NLRP3 knockout (Nlrp3-/-) mice, we demonstrated that GB1 administration significantly ameliorated colitis symptoms, as evidenced by improved body weight, disease activity index (DAI) scores, colon length, and histological damage in WT mice. Mechanistically, GB1 downregulated pro-inflammatory mediators (IL-6, NF-κB, and CD11b) while attenuating the expression of NLRP3 inflammasome components (ASC, Caspase-1, and IL-1β). Notably, these protective effects were abolished in Nlrp3-/- mice, confirming the essential role of NLRP3 in GB1-mediated mitigation of colitis. Furthermore, GB1 reinforced intestinal barrier integrity by preserving tight junctions, reducing permeability, and attenuating mucosal inflammation. Collectively, our findings highlight GB1 as a promising therapeutic candidate for colitis treatment, primarily through NLRP3 inflammasome suppression and intestinal barrier restoration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
- School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
- State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Beijing 100700, China.
ORCID-Profile: Xinan Huang
Förderung
- Guangzhou Science and Technology Plan Project
- National Major Scientific and Technological Special Project for "Significant New Drugs De-velopment"
- Key project at central·government level: The ability establishment of sustainable use for valuable Chinese medicine resources
Zitieren
APA
Zhou, Z., Wang, L., Liao, R., Chen, Q., Liu, C., Song, J., Deng, C., & Huang, X. (2025). The Effect of GB1 on DSS-Induced Colitis in WT and Nlrp3-/- Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094016
Vancouver
Zhou Z, Wang L, Liao R, Chen Q, Liu C, Song J, et al. The Effect of GB1 on DSS-Induced Colitis in WT and Nlrp3-/- Mice. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094016
BibTeX
@article{Zhou2025,
author = {Zhou, Ziyi and Wang, Lixian and Liao, Ruhe and Chen, Qin and Liu, Changhui and Song, Jianping and Deng, Changsheng and Huang, Xinan},
title = {The Effect of GB1 on DSS-Induced Colitis in WT and Nlrp3-/- Mice},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26094016}
}
EUVIMED